Ibex Investors’s Teladoc Health TDOC Stock Holding History

Ibex Investors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,589	Closed	-$224K	–	242
2018 Q3	$224K	Buy	+2,589	New	+$185K	0.12%	56

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Ibex Investors's TDOC Position: Q4 2018 in Review

Ibex Investors sold out of Teladoc Health (TDOC) in Q4 2018, closing a stake of 2,589 shares — an estimated $224K sold.

Ibex Investors first reported a position in TDOC in Q3 2018 and held it in 1 quarter. The position peaked at $224K in Q3 2018. 326 funds tracked by Wall St. Rank hold TDOC as of Q4 2018.

Ibex Investors reported no remaining Teladoc Health position as of Q4 2018 after selling out during the quarter.
Ibex Investors sold 2,589 Teladoc Health shares in Q4 2018, an estimated $224K.
Ibex Investors first reported a position in Teladoc Health in Q3 2018 and held it in 1 quarter.
Ibex Investors's Teladoc Health position peaked at $224K in Q3 2018.
326 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2018.

Based on Ibex Investors's 13F filing for Q4 2018, filed 13 Feb 2019.